Imstem Biotechnology is a biotechnology company focusing on developing cell therapeutic products derived from human pluripotent stem cells (hESC or iPSC) for tissue repair, treatment of neural, heart, vascular, blood system diseases, and autoimmune diseases.

Biotechnology

ImStem Biotechnology

Michael Men

Monica Chen

Edmund Mickunas

Richard Kim

Xiaofang Wang

The Scientific Advisory team at ImStem Biotechnology provides expert guidance on the development and application of cell therapeutic products derived from human pluripotent stem cells. They ensure scientific rigor, offer strategic insights, and assist in navigating regulatory pathways to optimize treatments for neural, heart, vascular, blood system, and autoimmune diseases.

Scientific Advisory

About

Team members

Other teams at ImStem Biotechnology

Leadership Team